Tilray Brands, Inc. Proceeds from Sale of Productive Assets
Tilray Brands, Inc. (TLRY) reported Proceeds from Sale of Productive Assets of $3.51 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2026-07-28
- Tilray Brands, Inc. proceeds from sale of productive assets for the quarter ending 2026-05-31 was $1.71M, a 71.47% decline year-over-year.
- Tilray Brands, Inc. proceeds from sale of productive assets for the quarter ending 2026-02-28 was $1.37M, a 578.71% increase year-over-year.
- Tilray Brands, Inc. proceeds from sale of productive assets for the quarter ending 2025-11-30 was $134.00K, a 77.78% decline year-over-year.
- Tilray Brands, Inc. proceeds from sale of productive assets for the quarter ending 2025-08-31 was $293.00K, a 946.43% increase year-over-year.
- Tilray Brands, Inc. proceeds from sale of productive assets for fiscal 2026 was $3.51M, a 48.61% decline from fiscal 2025.
- Tilray Brands, Inc. proceeds from sale of productive assets for fiscal 2025 was $6.82M, a 19.80% decline from fiscal 2024.
- Tilray Brands, Inc. proceeds from sale of productive assets for fiscal 2024 was $8.51M, a 97.70% increase from fiscal 2023.
- Tilray Brands, Inc. proceeds from sale of productive assets for fiscal 2023 was $4.30M, a 64.74% decline from fiscal 2022.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2026-05-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $3.08M derived: sum of 2 quarters · filed 2026-07-28 | $3.21M derived: sum of 3 quarters · filed 2026-07-28 | $3.51M 10-K · filed 2026-07-28 |
| 2026-02-28 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $1.50M derived: sum of 2 quarters · filed 2026-04-01 | $1.80M 10-Q · filed 2026-04-01 | $7.79M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $427.00K 10-Q · filed 2026-01-08 | $6.42M derived: sum of 3 quarters · filed 2026-07-28 | $6.62M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $293.00K 10-Q · filed 2025-10-09 | $6.28M derived: sum of 2 quarters · filed 2026-07-28 | $6.49M derived: sum of 3 quarters · filed 2026-07-28 | $7.09M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $6.19M derived: sum of 2 quarters · filed 2026-07-28 | $6.80M derived: sum of 3 quarters · filed 2026-07-28 | $6.82M 10-K · filed 2026-07-28 |
| 2025-02-28 | $202.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $805.00K derived: sum of 2 quarters · filed 2026-04-01 | $833.00K 10-Q · filed 2026-04-01 | $8.18M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $603.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $631.00K 10-Q · filed 2026-01-08 | $7.97M derived: sum of 3 quarters · filed 2026-07-28 | $8.78M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $28.00K 10-Q · filed 2025-10-09 | $7.37M derived: sum of 2 quarters · filed 2026-07-28 | $8.17M derived: sum of 3 quarters · filed 2026-07-28 | $8.20M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $8.14M derived: sum of 2 quarters · filed 2026-07-28 | $8.17M derived: sum of 3 quarters · filed 2026-07-28 | $8.51M 10-K · filed 2026-07-28 |
| 2024-02-29 | $801.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | $824.00K derived: sum of 2 quarters · filed 2025-04-08 | $1.17M 10-Q · filed 2025-04-08 | $3.29M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | $365.00K 10-Q · filed 2025-01-10 | $2.49M derived: sum of 3 quarters · filed 2025-07-29 | $2.51M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | $342.00K 10-Q · filed 2024-10-10 | $2.47M derived: sum of 2 quarters · filed 2025-07-29 | $2.49M derived: sum of 3 quarters · filed 2025-07-29 | $3.18M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-05-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $2.14M derived: sum of 2 quarters · filed 2025-07-29 | $2.84M derived: sum of 3 quarters · filed 2025-07-29 | $4.30M 10-K · filed 2025-07-29 |
| 2023-02-28 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $712.00K derived: sum of 2 quarters · filed 2024-04-09 | $2.17M 10-Q · filed 2024-04-09 | $2.85M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | $697.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | $2.16M 10-Q · filed 2024-01-09 | $2.84M derived: sum of 3 quarters · filed 2024-10-10 | $6.10M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $1.46M 10-Q · filed 2024-10-10 | $2.14M derived: sum of 2 quarters · filed 2024-10-10 | $5.40M derived: sum of 3 quarters · filed 2024-10-10 | $5.97M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | $679.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $3.94M derived: sum of 2 quarters · filed 2024-07-30 | $4.51M derived: sum of 3 quarters · filed 2024-07-30 | $12.21M 10-K · filed 2024-07-30 |
| 2022-02-28 | $3.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | $3.83M derived: sum of 2 quarters · filed 2023-04-10 | $11.53M 10-Q · filed 2023-04-10 | $11.53M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-11-30 | $568.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $8.26M 10-Q · filed 2023-01-09 | $8.27M derived: sum of 3 quarters · filed 2023-07-26 | $8.27M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-08-31 | $7.70M 10-Q · filed 2022-10-07 | $7.70M derived: sum of 2 quarters · filed 2023-07-26 | $7.70M derived: sum of 3 quarters · filed 2023-07-26 | |
| 2021-05-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $1.00K derived: sum of 2 quarters · filed 2023-07-26 | $6.61M 10-K · filed 2023-07-26 | |
| 2021-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | $6.61M 10-Q · filed 2022-04-06 | ||
| 2020-11-30 | $6.61M 10-Q · filed 2022-01-10 | |||
| 2020-05-31 | $1.41M 10-K · filed 2022-07-28 | |||
| 2019-05-31 | $42.00K 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |